Tag: Elecsys pTau217
-
Roche and Eli Lilly Win FDA Clearance for Alzheimer’s Blood Test
Roche and Eli Lilly received FDA clearance for Elecsys pTau217, a single-biomarker blood test designed to assess Alzheimer’s-related amyloid pathology.
-
Why pTau217 Can Reveal Alzheimer’s Pathology from Blood
pTau217 rises with Alzheimer’s-related brain pathology and can be measured in blood, enabling a simpler approach to amyloid assessment.